Laurence James Neil Cooper is President and CEO of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 1.8 Million shares of TCRT, which is worth approximately $3.74 Million. The most recent transaction as insider was on Jan 04, 2021, when has been sold 105,693 shares (Common Stock) at a price of $2.71 per share, resulting in proceeds of $286,428. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.8M
0% 3M change
0% 12M change
Total Value Held $3.74 Million

Laurence James Neil Cooper Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2021
SELL
Open market or private sale
$286,428 $2.71 p/Share
105,693 Reduced 5.55%
1,799,280 Common Stock
LJN

Laurence James Neil Cooper

President and CEO
Boston, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Track Activities on TCRT